Array BioPharma Inc (NASDAQ:ARRY) - Share price - Overview

Stock Report

Array BioPharma Inc ARRY

Last Price
$11.21

Day Change
-0.07|-0.62%

As of 21/11/2017
16:08:42 EST | USD
Minimum 15 Minutes Delay.

Last Close11.28
Day Range11.16 - 11.34
Mkt Cap2.22Bil
52-Wk Range6.73 - 13.40
Yield %-
ISINUS04269X1054
Volume2,644,068
P/E-15.15
P/S13.62
P/CF-44.70

Share Price

Financials
201520162017
More ...
Income Statement
Revenue51.91137.88150.85
Operating Income1.65-82.21-102.08
Net Income9.37-92.84-116.82
Basic EPS0.07-0.65-0.72
Avg. Diluted Shares Outstanding142143163
Balance Sheet
Current Assets191.05155.30270.18
Non Current Assets7.1613.608.97
Total Assets198.21168.90279.15
Current Liabilities42.4252.4369.55
Total Liabilities155.55206.83267.42
Total Equity42.65-37.9311.73
Cash Flow
Operating Cash Flow-5.79-70.09-39.35
Capital Expenditure-2.51-3.16-3.52
Free Cash Flow-8.30-73.25-42.87

In millions, except "Basic EPS". Currency is USD.

Company Profile

Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

June

Employees

209
Key Stats
More ...
Price/Earning TTM-15.24
Price/Book9.81
Price/Sales TTM13.62
Rev Growth (3 year avg)53.05
EPS Growth (3 year avg)-
Operating Margin % TTM-67.67
Net Margin % TTM-77.44
ROE TTM-
Debt/Equity11.42
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.